NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

Last Close
Jul 02 04:00PM ET
12.61
Dollar change
+0.81
Percentage change
6.86
%
Index- P/E- EPS (ttm)-5.27 Insider Own17.46% Shs Outstand37.44M Perf Week8.43%
Market Cap472.13M Forward P/E- EPS next Y-2.40 Insider Trans1.92% Shs Float30.90M Perf Month7.14%
Enterprise Value126.92M PEG- EPS next Q-0.49 Inst Own72.76% Short Float9.06% Perf Quarter31.90%
Income-78.08M P/S- EPS this Y47.55% Inst Trans2.29% Short Ratio10.20 Perf Half Y-33.67%
Sales0.00M P/B1.30 EPS next Y-18.24% ROA-37.74% Short Interest2.80M Perf YTD-34.97%
Book/sh9.66 P/C1.35 EPS next 5Y13.33% ROE-39.06% 52W High33.00 -61.79% Perf Year-48.99%
Cash/sh9.32 P/FCF- EPS past 3/5Y33.13% 36.88% ROIC-21.37% 52W Low5.49 129.90% Perf 3Y-21.85%
Dividend Est.- EV/EBITDA- Sales past 3/5Y- - Gross Margin- Volatility8.00% 7.27% Perf 5Y-72.09%
Dividend TTM- EV/Sales- EPS Y/Y TTM-5.74% Oper. Margin- ATR (14)0.85 Perf 10Y-98.37%
Dividend Ex-DateAug 26, 2024 Quick Ratio30.03 Sales Y/Y TTM- Profit Margin- RSI (14)59.36 Recom1.00
Dividend Gr. 3/5Y- - Current Ratio30.03 EPS Q/Q69.70% SMA204.70% Beta-0.36 Target Price39.29
Payout- Debt/Eq0.00 Sales Q/Q- SMA5013.73% Rel Volume0.91 Prev Close11.80
Employees28 LT Debt/Eq0.00 EarningsMay 14 AMC SMA200-23.02% Avg Volume274.43K Price12.61
IPOAug 08, 1997 Option/ShortYes / Yes EPS/Sales Surpr.21.31% - Trades Volume249,915 Change6.86%
Date Action Analyst Rating Change Price Target Change
May-22-25Initiated BTIG Research Buy $44
Feb-04-25Initiated Wolfe Research Outperform $20
Oct-11-24Initiated Stifel Buy $49
Oct-07-24Initiated H.C. Wainwright Buy $45
Sep-17-24Initiated Leerink Partners Outperform $44
Sep-16-24Initiated TD Cowen Buy
Sep-13-24Initiated Jefferies Buy $40
Feb-27-18Initiated Ascendiant Capital Markets Buy $2
Oct-09-13Initiated Dawson James Buy $3.75
Jul-01-25 04:01PM
May-27-25 03:32PM
May-21-25 07:00AM
May-20-25 04:01PM
May-14-25 04:15PM
07:00AM Loading…
Apr-29-25 07:00AM
Mar-07-25 08:30AM
Mar-06-25 04:09PM
Feb-19-25 07:00AM
Dec-20-24 07:15AM
Dec-19-24 07:00AM
Dec-18-24 07:00AM
Nov-19-24 08:00AM
Nov-13-24 04:25PM
Nov-04-24 07:00AM
07:08AM Loading…
Sep-25-24 07:08AM
Sep-12-24 07:05AM
07:00AM
Sep-03-24 07:00AM
Aug-29-24 04:50PM
Aug-26-24 07:30PM
Aug-23-24 04:30PM
Aug-16-24 04:15PM
Aug-01-24 04:15PM
Jun-28-24 02:16AM
Jun-26-24 11:08PM
May-14-24 01:48PM
Apr-25-24 09:55PM
04:15PM
Apr-03-24 02:30PM
12:00PM Loading…
12:00PM
07:30AM
Feb-01-24 04:35PM
Oct-18-23 04:25PM
Jul-21-23 04:25PM
Jul-13-23 11:30AM
Apr-24-23 04:25PM
Feb-24-23 04:20PM
Feb-03-23 10:19AM
Dec-19-22 04:05PM
Nov-14-22 09:24AM
Oct-28-22 04:15PM
Aug-02-22 04:15PM
Jul-18-22 06:14AM
Jun-21-22 04:05PM
May-05-22 04:15PM
May-02-22 04:15PM
Apr-18-22 04:30PM
Apr-05-22 01:35AM
Apr-01-22 07:09AM
Mar-31-22 04:15PM
Mar-14-22 04:15PM
Mar-07-22 04:30PM
Feb-08-22 04:21AM
Jan-04-22 08:30AM
Dec-02-21 08:30AM
Nov-20-21 07:01AM
Nov-09-21 04:15PM
Nov-02-21 04:15PM
Oct-29-21 07:03AM
06:26AM
Oct-28-21 04:30PM
Sep-16-21 08:30AM
Aug-16-21 08:05AM
Aug-12-21 01:15AM
Aug-09-21 08:00AM
Aug-04-21 04:15PM
Jul-28-21 08:00AM
Jul-13-21 08:00AM
Jul-09-21 08:00AM
Jul-08-21 11:20AM
Jul-07-21 08:00AM
Jun-23-21 09:35AM
May-11-21 04:15PM
May-05-21 04:05PM
May-03-21 04:30PM
Mar-18-21 04:30PM
Feb-13-21 01:09AM
Dec-15-20 08:30AM
Dec-09-20 05:40PM
Nov-23-20 12:28PM
08:30AM
Nov-02-20 08:30AM
Oct-07-20 08:30AM
Oct-05-20 04:30PM
Sep-21-20 08:00AM
Aug-17-20 08:49AM
Aug-12-20 08:00AM
Aug-05-20 04:15PM
Jul-07-20 08:30AM
Jun-03-20 09:56AM
09:56AM
Jun-01-20 08:20AM
May-29-20 12:24PM
09:59AM
May-28-20 04:19PM
12:14PM
10:27AM
08:00AM
May-07-20 08:30AM
Oruka Therapeutics, Inc. is a biotechnology company, which focuses on developing novel monoclonal antibody therapeutics for PsO and other I&I indications. Its pipeline includes ORKA-001 and ORKA-002. The company is headquartered in Menlo Park, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Venrock Healthcare Capital Par10% OwnerFeb 14 '25Buy11.4488,7941,015,8034,148,428Feb 27 06:42 PM
Venrock Healthcare Capital Par10% OwnerFeb 13 '25Buy11.6314,950173,8684,059,634Feb 27 06:42 PM
Venrock Healthcare Capital Par10% OwnerFeb 12 '25Buy11.868,971106,3964,044,684Feb 27 06:42 PM
Venrock Healthcare Capital Par10% OwnerFeb 11 '25Buy10.959,593105,0434,035,713Feb 27 06:42 PM
Venrock Healthcare Capital Par10% OwnerFeb 10 '25Buy10.905746,2574,026,120Feb 27 06:42 PM
JANUS HENDERSON GROUP PLC10% OwnerAug 16 '24Buy2.935,81817,0672,117,213Aug 20 02:23 PM
JANUS HENDERSON GROUP PLC10% OwnerJul 24 '24Buy3.20189,856606,8732,081,168Jul 26 10:50 AM
JANUS HENDERSON GROUP PLC10% OwnerJul 25 '24Buy3.0530,22792,2922,111,395Jul 26 10:50 AM
JANUS HENDERSON GROUP PLC10% OwnerJul 03 '24Buy3.55166,042589,5651,648,577Jul 12 07:38 PM
JANUS HENDERSON GROUP PLC10% OwnerJul 11 '24Buy3.4594,537326,3041,891,312Jul 12 07:38 PM
JANUS HENDERSON GROUP PLC10% OwnerJul 10 '24Buy3.4655,463192,1301,796,775Jul 12 07:38 PM
JANUS HENDERSON GROUP PLC10% OwnerJul 08 '24Buy3.4647,492164,1901,724,395Jul 12 07:38 PM
JANUS HENDERSON GROUP PLC10% OwnerJul 05 '24Buy3.4328,32697,0651,676,903Jul 12 07:38 PM
JANUS HENDERSON GROUP PLC10% OwnerJul 09 '24Buy3.4316,91758,0911,741,312Jul 12 07:38 PM